Glyphic Biotechnologies
Glyphic Biotechnologies is a biotechnology company that develops a protein sequencing platform.
Glyphic Biotechnologies is active in the biotechnology, health care, life science space based in Greater New York Area, East Coast, Northeastern US, founded in 2021.
Glyphic Biotechnologies is positioned in biotechnology, health care, life science, a segment that rewards a clear, focused offering.
The company is recorded as being based in Greater New York Area, East Coast, Northeastern US.
It is recorded at the Seed stage.
Its team size is recorded as c_00011_00050 employees.
Public records show total funding of about $7.8M.
| Sector | Biotechnology, Health Care, Life Science |
|---|---|
| Headquarters | Greater New York Area, East Coast, Northeastern US |
| Country | United States |
| Founded | 2021 |
| Employees | c_00011_00050 |
| Stage | seed |
| Total funding | $7,783,799 |
Website: www.glyphic.bio
Browse related
Sign in to view the contact information we hold for Glyphic Biotechnologies.
Create a free account
Create a free account